Baird Medical Investment Holdings Ltd
BDMD1.170USD
-0.040-3.31%
Handelsschluss 11/05, 16:00（ET）Kurse um 15 Minuten verzögert
29.90MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Baird Medical Investment Holdings Ltd Unternehmen
Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The Company is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.
Baird Medical Investment Holdings Ltd Informationen
BörsenkürzelBDMD
Name des UnternehmensBaird Medical Investment Holdings Ltd
IPO-datumDec 13, 2021
CEOMr. Joe Ragan
Anzahl der mitarbeiter143
WertpapierartOrdinary Share
GeschäftsjahresendeDec 13
AddresseRoom 202, 2/F, Baide Building, Building 11, No.15, Rongtong Street, Yuexiu District
StadtGUANGZHOU
BörseNASDAQ Capital Market Consolidated
LandChina
Postleitzahl- -
Telefon
Websitehttps://ir.bairdmed.com/
BörsenkürzelBDMD
IPO-datumDec 13, 2021
CEOMr. Joe Ragan
Führungskräfte von Baird Medical Investment Holdings Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Mr. Jin Xu
Mr. Jin Xu
Quality Assurance Department Manager
Quality Assurance Department Manager
--
--
Mr. Wei Xu
Mr. Wei Xu
Merchandising Department Manager
Merchandising Department Manager
--
--
Mr. Robin Yang
Mr. Robin Yang
Investor Relations
Investor Relations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2024
FY2023
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
Nach RegionUSD
Name
Umsatz
Anteil
China (Mainland)
37.04M
100.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
Aktionärsstatistik
Aktualisiert: Sun, Nov 2
Aktualisiert: Sun, Nov 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Wu (Haimei)
71.59%
ExcelFin SPAC LLC
18.68%
Grand Fortune Capital (H.K.) Co, Ltd.
9.65%
Periscope Capital
0.49%
Highbridge Capital Management, LLC
0.49%
Aktionäre
Aktionäre
Anteil
Wu (Haimei)
71.59%
ExcelFin SPAC LLC
18.68%
Grand Fortune Capital (H.K.) Co, Ltd.
9.65%
Periscope Capital
0.49%
Highbridge Capital Management, LLC
0.49%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
71.59%
Corporation
28.32%
Investment Advisor/Hedge Fund
0.79%
Investment Advisor
0.53%
Hedge Fund
0.49%
Research Firm
0.29%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
45
538.38K
2.11%
-4.07M
2025Q2
48
25.90M
101.35%
+14.65M
2025Q1
81
6.17M
89.94%
-16.81M
2024Q4
86
6.26M
24.13%
-18.81M
2024Q3
89
6.01M
23.82%
-19.60M
2024Q2
91
6.99M
95.36%
-19.67M
2024Q1
95
7.38M
92.34%
-14.39M
2023Q4
94
1.73M
21.20%
-21.42M
2023Q3
93
4.65M
96.02%
-18.05M
2023Q2
90
5.14M
97.70%
-22.44M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Wu (Haimei)
18.30M
71.59%
+18.30M
--
May 13, 2025
ExcelFin SPAC LLC
4.77M
18.68%
-976.59K
-16.98%
May 13, 2025
Grand Fortune Capital (H.K.) Co, Ltd.
2.46M
9.65%
+2.46M
--
May 13, 2025
Periscope Capital
125.00K
0.49%
--
--
Jun 30, 2025
Highbridge Capital Management, LLC
125.00K
0.49%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
91.45K
0.36%
+34.51K
+60.61%
Jun 30, 2025
Northern Trust Investments, Inc.
52.44K
0.21%
+52.44K
--
Jun 30, 2025
Susquehanna International Group, LLP
44.67K
0.17%
+44.67K
--
Jun 30, 2025
Jane Street Capital, L.L.C.
38.84K
0.15%
+38.84K
--
Jun 30, 2025
Virtu Americas LLC
26.36K
0.1%
+26.36K
--
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
